Bacterial and fungal biofilm infections
A Simon Lynch1, Gregory T Robertson
1Cumbre Pharmaceuticals Inc., Dallas, Texas 75235-2304, USA. slynch@cumbrepharma.com
Abstract:
Biofilms are communal structures of microorganisms encased in an exopolymeric coat that form on both natural and abiotic surfaces and have been associated with a variety of persistent infections that respond poorly to conventional antibiotic chemotherapy. Biofilm infections of certain indwelling medical devices by common pathogens such as staphylococci are not only associated with increased morbidity and mortality but are also significant contributors to the emergence and dissemination of antibiotic resistance traits in the nosocomial setting. Current treatment paradigms for biofilm-associated infections of semipermanent indwelling devices typically involve surgical replacement of the device combined with long-term antibiotic therapy and incur high health care costs. This review summarizes the existing data relating to the nature, prevalence, and treatment of biofilm-associated infections and highlights experimental approaches and therapies that are being pursued toward more effective treatments.
Insights
Biofilms, microbial communities on surfaces, cause persistent infections resistant to antibiotics. New treatments are needed to combat these challenging infections and reduce healthcare costs.
Area of Science:
- Microbiology
- Infectious Diseases
- Biomedical Engineering
Background:
- Biofilms are microbial communities encased in an exopolymeric matrix, adhering to surfaces.
- Biofilm infections are linked to persistent, difficult-to-treat infections, particularly with indwelling medical devices.
- These infections contribute to increased morbidity, mortality, and the spread of antibiotic resistance in healthcare settings.
Purpose of the Study:
- To review the current understanding of biofilm-associated infections.
- To summarize treatment strategies for biofilm infections, including conventional and emerging therapies.
- To highlight experimental approaches for more effective biofilm infection management.
Main Methods:
- Literature review of existing data on biofilm nature, prevalence, and treatment.
- Analysis of current treatment paradigms for biofilm-associated infections.
- Identification and summary of experimental therapies and approaches.
Main Results:
- Biofilms are a significant challenge in healthcare, associated with persistent infections and antibiotic resistance.
- Current treatments often involve device replacement and prolonged antibiotic therapy, with high costs.
- Experimental therapies show promise for improved biofilm infection management.
Conclusions:
- Effective treatment of biofilm infections requires novel strategies beyond conventional antibiotic chemotherapy.
- Further research into experimental approaches is crucial for developing better therapies.
- Addressing biofilm infections is essential for reducing healthcare-associated infections and antibiotic resistance.
More Related Videos
Related Concept Videos
Bacterial Signaling
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Biofilms
Colonisation of Pathogens


